- Breast Cancer
- Cancer Control
- Chemotherapy
- Diagnostics and Screening
- Gastrointestinal Cancers
- Genitourinary Cancers
- Geriatric Oncology
- Gynecological Oncology
- Head, Neck and Thyroid Cancers
- Hematology
- Hematological Malignancies
- Imaging
- Lung Cancer
- Neurological Cancers
- Pediatric Oncology
- Radiotherapy
- Sarcomas and Melanomas
- Supportive Oncology
Media Gallery
RTI Electronics provides complete quality assurance solutions for X-ray modalities and facilities.
RTI Electronics is specialized in test instruments for X-ray QA and Service. Our multimeters can "do it all in one shot" -- kV, time, dose, dose rate, HVL, pulsed fluoroscopy and total filtration.
SAN ANTONIO -- The most anticipated reports here at the San Antonio Breast Cancer Symposium focused on new ways to use old drugs, particularly trastuzumab (Herceptin) and bisphosphonates. But exciting results from new agents in the pipeline stole some of the thunder.
Watch Kimberly L. Blackwell, MD, associate professor of medicine and director of the Clinical Trials Program in Breast Cancer at Duke University Medical Center talk about "Updated Survival Analysis of a Randomized Study of Lapatinib Alone or in Combination with Trastuzumab in Women with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab Therapy.
Watch Gad Rennert, MD, PhD, chairman of the Department of Community Medicine and Epidemiology at Carmel Medical Center and Technion Faculty of Medicine as well as Director of the CHS National Israeli Cancer Control Center. Listen to him talk about Use of Bisphosphonates and Risk of Postmenopausal Breast Cancer.
Watch Carlos L. Arteaga, MD, the Donna S. Hall Chair in Breast Cancer Research at the Vanderbilt-Ingram Cancer Center, professor of Medicine and Cancer Biology at Vanderbilt, American Cancer Society Clinical Research Professor and Director of the Vanderbilt Breast Cancer Program. Listen to him talk about Translational Insights for Clinical Research and Practice.
